輸入代號或公司名稱後按 Enter
1733

五鼎

-0.20 (-0.65%)最後更新 2026-09-11
台灣 · 上市 · 生技醫療業
30.8066成交張數16.21本益比1.66股價淨值比4.22%殖利率2026-09-11資料日期

每股盈餘

柱為單季 EPS,線為近四季合計;近十年

季度單季 EPS年增近四季 EPS歸屬母公司淨利(億)淨利率ROE(季)ROE(近四季)
2026Q20.3727.6%1.900.377.8%2.00%10.43%
2026Q10.8130.6%1.820.8115.6%4.40%10.15%
2025Q40.5031.6%1.630.5011.4%2.72%8.82%
2025Q30.22-35.3%1.510.225.1%1.23%8.43%
2025Q20.297.4%1.630.295.6%1.61%9.18%
2025Q10.62113.8%1.610.6211.1%3.46%9.24%
2024Q40.38153.3%1.280.388.5%2.14%7.07%
2024Q30.34-10.5%1.050.336.5%1.88%5.88%
2024Q20.270.0%1.090.276.2%1.58%6.28%
2024Q10.29-19.4%1.090.296.5%1.66%6.37%
2023Q40.15-65.1%1.160.153.7%0.85%6.41%
2023Q30.38-40.6%1.440.389.2%2.15%8.09%
2023Q20.27-6.9%1.700.276.5%1.56%9.87%
2023Q10.36-21.7%1.720.368.2%2.02%9.79%
2022Q40.43-47.6%1.820.438.5%2.40%10.18%
2022Q30.640.0%2.210.6410.6%3.68%12.80%
2022Q20.2926.1%2.210.294.8%1.66%12.89%
2022Q10.4635.3%2.150.468.7%2.57%12.28%
2021Q40.82148.5%2.030.8214.5%4.77%11.90%
2021Q30.64178.3%1.540.6412.6%3.79%9.36%
2021Q20.23-14.8%1.130.224.6%1.32%6.82%
2021Q10.34183.3%1.170.345.9%2.05%6.96%
2020Q40.33-59.3%0.950.337.2%2.02%5.71%
2020Q30.231.430.234.5%1.44%8.88%
2020Q20.27-3.6%1.030.275.1%1.64%6.42%
2020Q10.12-45.5%1.040.122.3%0.71%6.21%
2019Q40.811.140.8112.1%4.93%6.86%
2019Q3-0.17-123.9%-0.05-0.17-3.6%-1.03%-0.25%
2019Q20.28-37.8%0.830.285.2%1.70%5.14%
2019Q10.2229.4%1.000.224.1%1.31%5.93%
2018Q4-0.38-184.4%0.95-0.37-7.1%-2.24%5.75%
2018Q30.71222.7%1.780.7012.7%4.28%10.73%
2018Q20.45-22.4%1.290.459.0%2.72%8.02%
2018Q10.171.420.173.6%1.02%8.37%
2017Q40.450.860.459.5%2.72%5.04%
2017Q30.222100.0%-0.900.224.6%1.37%-5.15%
2017Q20.58-10.8%-1.110.5813.7%3.51%-6.39%
2017Q1-0.39-157.3%-1.04-0.39-9.2%-2.27%-5.59%
2016Q4-1.310.03-1.30-35.3%-7.26%
2016Q30.010.010.3%0.07%